semaglutide made of | C187H291N45O59 | CID 56843331 Weight-loss jab could be made

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has a slightly different receptor activity profile and may be tolerated differently, though gastrointestinal side effects remain common

Helman and Himmel have no conflicts of interest to declare References Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB

Currently, Mounjaro is not covered but may be added in the future

"At Noom, we help people understand that scientifically the best way to achieve weight loss and optimal health is through a program that pairs behavior change with the right medication when needed." Dr

they also appear to have anti-inflammatory properties and other beneficial effects that are not yet fully understood

Whether these agents benefit compensated cirrhosis (F4) in preventing decompensation remains unclear